EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, and Biological Evaluation of Novel Quinazoline–Thiazole Hybrids As Potential Anticancer Agents

Sobhi M Gomha iD, Sami A Al-Hussain, Basant Farag, Nahlah A Alhadhrami, Magdi E A Zaki iD, AbdElAziz A Nayl iD, Abdelwahed R Sayed, Ahmed A M El-Reedy

Journal of Biochemical and Molecular Toxicology · 2026-06 · 40 (6)

DOI: 10.1002/jbt.70944 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 02.06.2026. Verfasst von Sobhi M Gomha und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Islamic University of Madinah, Madinah, Saudi Arabia. Hauptthemen laut MEDLINE: Thiazoles, Antineoplastic Agents, Quinazolines, Drug Design. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A convenient synthetic route was developed for the preparation of structurally diverse quinazolinone–thiazole hybrids using a common thiosemicarbazide intermediate ( 2 ), which underwent cyclization with different electrophiles to afford three series of derivatives ( 4a–e/6, 8a–c, and 11a,b/13 ). The structures of all synthesized compounds were confirmed by IR, NMR, MS, and elemental (CHN) analyses. The cytotoxic activity of the obtained compounds was evaluated against HCT‐116 human colon cancer cells using the MTT assay after 24 h of incubation. Compounds 4b (IC 50 = 3.82 µM), 4a (IC 50 = 4.07 µM), and 11b (IC 50 = 4.09 µM) were the most active derivatives, showing activity comparable to doxorubicin (IC 50 = 4.17 µM), while compound 6 also showed good activity (IC 50 = 5.92 µM). Preliminary structure–activity relationship analysis indicated that electron‐donating aryl substituents such as methyl and methoxy groups enhanced the activity in the 4‐series, whereas electron‐withdrawing substituents such as chloro, bromo, and nitro reduced it; in the 11‐series, the ethyl ester derivative 11b was more potent than the corresponding acetyl derivative 11a . Cytotoxicity against the non‐tumor LLC‐MK2 cell line showed that compounds 4a, 4b, 6, and 11b exhibited IC 50 values > 100 µM, indicating a favorable preliminary selectivity toward the cancer cell line. Molecular docking against human uridine 5′‐monophosphate synthase (UMPS, PDB: 7OUZ) supported the observed activity trends, and in silico ADMET prediction suggested acceptable drug‐like and pharmacokinetic properties. Overall, compounds 4a, 4b, and 11b emerged as promising anticancer candidates for further mechanistic and selectivity studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiazolesAntineoplastic AgentsQuinazolinesDrug DesignHumansStructure-Activity RelationshipHCT116 CellsMolecular Docking SimulationDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

ADMET profilinganticancer activityhydrazonoyl chloridesmolecular dockingquinazolinesthiazoles

Substanzen

ThiazolesAntineoplastic AgentsQuinazolines

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Science, Islamic University of Madinah, Madinah, Saudi Arabia.
  • Department of Chemistry, Faculty of Science, Imam Mohammed Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
  • Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, Egypt.
  • Chemistry Department, Faculty of Science, Taibah University, Madinah, Saudi Arabia.
  • Department of Chemistry, College of Science, Jouf University, Sakaka, Al Jouf, Saudi Arabia.
  • Institute of Basic and Applied Science,, Egypt-Japan University of Science and Technology, Alexandria, Egypt.

ORCID-Profile: Sobhi M Gomha, Magdi E A Zaki, AbdElAziz A Nayl

Förderung

  • Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU)

Zitieren

APA

Gomha, S. M., Al-Hussain, S. A., Farag, B., Alhadhrami, N. A., Zaki, M. E. A., Nayl, A. A., Sayed, A. R., & El-Reedy, A. A. M. (2026). Design, Synthesis, and Biological Evaluation of Novel Quinazoline–Thiazole Hybrids As Potential Anticancer Agents. Journal of Biochemical and Molecular Toxicology, 40(6). https://doi.org/10.1002/jbt.70944

Vancouver

Gomha SM, Al-Hussain SA, Farag B, Alhadhrami NA, Zaki MEA, Nayl AA, et al. Design, Synthesis, and Biological Evaluation of Novel Quinazoline–Thiazole Hybrids As Potential Anticancer Agents. Journal of Biochemical and Molecular Toxicology. 2026;40(6). doi:10.1002/jbt.70944

BibTeX
@article{Gomha2026,
  author = {Gomha, Sobhi M and Al-Hussain, Sami A and Farag, Basant and Alhadhrami, Nahlah A and Zaki, Magdi E A and Nayl, AbdElAziz A and Sayed, Abdelwahed R and El-Reedy, Ahmed A M},
  title = {Design, Synthesis, and Biological Evaluation of Novel Quinazoline–Thiazole Hybrids As Potential Anticancer Agents},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  volume = {40},
  number = {6},
  doi = {10.1002/jbt.70944}
}
Kostenlos starten →